Bij de planning van een epilepsiechirurgische ingreep is het uitgangspunt om een balans te vinden tussen de grootst mogelijke postoperatieve aanvalsreductie en de best mogelijke neurocognitieve uitkomst. Wij hebben bij een groep van 24 patiënten die een minimale temporaalkwabresectie ondergingen, een retrospectieve studie gedaan naar de neuropsychologische effecten op het verbale geheugen.
Worldwide, meaning and valence of words are being examined and weighed. This also occurs in healthcare, where campaigns demand attention for the fact that being terminally ill does not mean that there are no treatments left. Such efforts are commendable as there is room for improvement in the communication between healthcare providers and patients and healthcare providers are not equally well equipped to communicate effectively. Still, a US study in palliative surgery suggests that patients do not prefer one particular communication framework over another, tailoring of words seems the way to go. This may be especially beneficial for patients with a limited level of health literacy. Communication tools like the 'teach back' method, e-learnings and language guides can furthermore support healthcare providers in palliative care to continue to choose their words carefully with patients with a limited life expectancy.
Neuroleptic malignant syndrome and serotonin syndrome are two syndromes whose molecular bases remain poorly understood. The phenotypes of both syndromes overlap with other syndromes that have a clear genetic background, in particular RYR1-related malignant hyperthermia. Through a literature review, performed according to the PRISMA guidelines, we aimed to report the clinical features of both syndromes, and the results of genetic testing performed. 10 case series and 99 case reports were included, comprising 134 patients. A male predominance of 58% was found. The median age was 35 (range 4-84) years. Eight patients experienced recurrent episodes of rhabdomyolysis. Genetic analysis was performed in eleven patients (8%), revealing four RYR1 variants, three likely benign (p.Asp849Asn, p.Arg4645Gln, p.Arg4645Gln) and one variant of uncertain significance (p.Ala612Thr). This review underlines that a subset of patients with neuroleptic malignant syndrome and serotonin syndrome develop recurrent episodes of rhabdomyolysis. This recurrent pattern suggests a possible underlying (genetic) susceptibility. However, the genetic background of neuroleptic malignant syndrome and serotonin syndrome has only been investigated to a very limited degree so far. The increasing availability of next generation sequencing offers an opportunity to identify potentially associated genetic backgrounds, especially in patients with recurrent episodes or a positive family history.
Major advances have been made in the identification of genetic neurodevelopmental disorders and psychological (dis)functioning among persons with intellectual disabilities. This chapter first provides an overview of developments on the topic. Thereafter, our preference to study “dual diagnosis” from a neuropsychological perspective is described, building upon the increasing opportunities in genetic testing and beyond classificatory diagnosis of psychiatric conditions (e.g., DSM, ICD) in genetic neurodevelopmental disorders. This implies a multimethod assessment of cognitive functioning and understanding behavior from a contextual perspective, across the life span. Applying this neuropsychological clinical research strategy provides opportunities for developing and implementing (multidisciplinary) treatment strategies, as is shown in the syndrome descriptions in Chap. 4. Common conditions such as Fragile X syndrome and Noonan syndrome are reviewed as well as several rare genetic syndromes (e.g., Kleefstra syndrome, KBG syndrome, and Phelan-McDermid syndrome) with typically co-occurring mental health disorders and/or challenging behaviors. Special attention is paid to Prader-Willi syndrome, because it typically illustrates the complex interplay of the syndrome-bound phenomena and the great benefits of interdisciplinary study thereof. Resulting clinical strategies that may emerge from the advocated genetic neuropsychological paradigm are shortly addressed, including future vistas on this dynamic and rapidly developing field.
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.